Where does CytoVale's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across CytoVale's 3 recorded funding rounds.

Premier Alternatives

CytoVale

South San Francisco, CA · Founded 2013 · Privately Held (backing)

Developer of biophysical markers designed to revolutionize diagnostics using cell mechanics and machine learning. CytoVale is based in South San Francisco, CA and was founded in 2013. Its last known valuation is $340 million. It has raised $228 million across 3 recorded rounds; the latest was a $16.4 million debt round in Dec 2020.

Last price · $/share

—

Implied valuation

$340.0M

Total raised

$228.2M

Last round

Debt

Dec 2020

Cap table — not yet on record

CytoVale's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of CytoVale with a free account

·The complete investor list: 35 names
·Watch CytoVale: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about CytoVale

Where does CytoVale's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across CytoVale's 3 recorded funding rounds.